The fragile X syndrome is a common cause of mental impairment. In view of the low reproductive fitness of affected males, the high incidence of the syndrome has been suggested to be the result of a high rate of new mutations occurring exclusively in the male germline. Extensive family studies, however, have failed to identify any cases of a new mutation. Alternatively, it has been suggested that a selective advantage of unaffected heterozygotes may, in part, explain the high incidence of the syndrome. Molecular-investigations have shown that the syndrome is caused by the amplification of a CGG trinucleotide repeat in the FMR-1 gene which leads to the loss of gene expression. Further to this, genetic studies have suggested that there is evidence of linkage disequilibrium between the fragile X disease locus and flanking polymorphic markers. More recently, this analysis has been extended and has led to the observation that a large number of fragile X chromosomes appear to be lineage descendants of founder mutation events. Here, we present a study of the FRAXACI polymorphic marker in our patient cohort. We find that its allele distribution is strikingly different on fragile X chromosomes, confirming the earlier observations and giving further support to the suggestions of a fragile X founder effect. (J7 Med Genet 1993;30:647-50) from identifying a de novo microdeletion in a male with the typical characteristics of the syndrome in the absence of fragile X expression cytogenetically.'6
The fragile X syndrome is the most frequent familial form of mental retardation and may be responsible for up to 50% of all X linked mental retardation.'2 It is characterised clinically by an IQ typically in the range 35 to 50, elongated facies (associated with oedema, tissue thickening, and prognathism) with large everted ears and macro-orchidism. The syndrome is also associated with the expression of a rare folate sensitive fragile site at Xq27. 3.34 Extensive genetic and physical mapping has led recently to the isolation of a gene, FMR-1, in Xq27 which is defective in the fragile X syndrome.5 Molecular studies have identified a stepwise amplification of a trinucleotide CGG:CCG repeat element within the 5' of the FMR-1 gene on the fragile X chromosome.* '2 In unaffected carriers, the amplification is small and the gene functions normally. Upon further amplification, the CGG array expands dramatically and as a consequence the FMR-1 gene promoter becomes highly methylated and gene activity is lost.'315 Confirmatory evidence that the FMR-1 gene is indeed responsible for the clinical features of the syndrome has come from identifying a de novo microdeletion in a male with the typical characteristics of the syndrome in the absence of fragile X expression cytogenetically. '6 The fragile X syndrome is found with a frequency of 0 3 per 1000 males and 0-2 to 0-6 per 1000 females and segregation studies have suggested an overall carrier rate of 1/800.'7 18 As the reproductive fitness of affected hemizygous and heterozygous females is low, and the mutation is constantly being lost from the population, this high frequency requires an explanation. Sherman et al'9 suggested that the high incidence of the fragile X mutation was the result of a high new mutation rate in the order of 2-4 x 10-4 in sperm. However, molecular analyses have failed to identify any sporadic cases suggesting that the mutation is being carried through generations by normal transmitting males and normal carrier females. An alternative hypothesis is that a selective advantage in unaffected carriers may play a role in maintaining the high incidence of the syndrome.202' In this case, compensation for the loss of mutant alleles through reproductive failure is suggested to be achieved by a higher reproductive ability of unaffected and mildly affected subjects.
With the isolation of the FMR-1 gene and flanking polymorphic markers, it is now possible to map genetic haplotypes on the fragile X chromosome. Richards et aP2 have recently reported evidence for linkage disequilibrium between two dinucleotide markers and the fragile X mutation. Linkage disequilibrium mapping is based upon the expectation that in close proximity to the mutant gene, chromosomes descended from a common ancestral mutation will show a common haplotype reflecting that of the original ancestral chromosome. These observations suggest that most of the fragile X mutations we see today are the result of one or more founder mutations. In this study we have analysed the alleles of the closely linked AC dinucleotide marker FRAXAC1 in a large cohort of normal and fragile X subjects of European origin. The distribution of alleles in the fragile X population is significantly different from that in the normal population, confirming the observations of Richards et al. 22 Fragile X mutations on other haplotypes are also found, and these may be understood in the light of new evidence of mutation rates in simple repeat elements.
Materials and methods
Genomic DNA was prepared from peripheral blood lymphocytes and cell lines by standard methods. The non-fragile X samples were made up of unrelated subjects including members of the CEPH collection of DNA. Analysis 
